Physician profile
Michael Reshad
NPI 1720196587
$6,927.58
in general payments reported to CMS, 2019-2025
7 companies · $51.14 in 2025
The $51.14 reported for 2025 was less than what a typical Periodontics provider received nationally (typical 2025 total: $111).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $124 · 2020: $2,288 · 2021: $3,315 · 2022: $675 · 2023: $300 · 2024: $175 · 2025: $51.14.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $475 · Food and Beverage: $51.14.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $475.00 |
| Food and Beverage | $51.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $5,075.00 | 2020-2021 | |
| Zimvie INC. | $1,150.00 | 2022-2024 | |
| Straumann USA LLC | $512.50 | 2020 | |
| Orapharma, A Division of Bausch Health US, LLC | $138.94 | 2019-2021 | |
| American Orthodontics Corporation | $23.13 | 2025 | Radiance, Empower-Ceramic, Master Series |
| Kulzer, LLC | $14.40 | 2025 | |
| Geistlich Pharma, North America, INC. | $13.61 | 2025 | Biomaterials |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Reshad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.